The RFK ‘Wild’ Card: Uncertainty For US FDA In A Second Trump Term

No matter the role Kennedy is given in a potential Trump Administration, he could be a wild card for the FDA and its ability to operate. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Elections

More from Agency Leadership